Continuous change as a constant challenge.
From Product Market to Customer Market
Essentially these are (a) the capping of increasing healthcare costs in the industrialised states by further statutory regulation, (b) an increasing awareness of health also in the rapidly growing markets as well as (c) the introduction of innovative drugs whose application for physicians and patients is becoming more complicated. The pharmaceutical industry faces further change which will also call into question the current business model and bring completely new demands for employees.
From Insourcing to Outsourcing
The targeted outsourcing of business processes to increase efficiency but also the establishment of completely new fields of activity offer an opportunity for sustainable growth in the years to come. The outsourcing of business processes means therefore an integration of outsourcing partners so that this step is successful. Pharmexx knows the local legal framework as well as the specific success factors and comprehensively advises its customers before the start of each outsourcing project. Well-planned and co-ordinated communication is critical for success during these times of change. Our project managers will accompany you through this.
From Sales Representative to Key Account Manager
Sales and Marketing will always adapt to increasingly complex decision-making. As a consequence the job profile of a sales representative in most markets is changing more to that of a key account manager. We prepare our employees for this change by appropriate development programmes. Key opinion leader management is becoming more important at a global and local level. We have the specialists, the access and therefore can offer you a quicker “take-off” at product launch.
From Prescription to Compliance and Adherence
In many countries additional support for patients and their families at home by trained personnel is becoming more important for effective and efficient healthcare. The influences on compliance and adherence are multifactorial and specific concepts are required to increase these. First models in various countries show that together with Pharmexx, therapy outcome can be improved. An interesting approach both for the pharmaceutical company and for the cost-bearer. New opportunities for employees with good and exciting perspectives.